Investor Summit is the largest independent investor conference on the East Coast. This independence allows a sharp focus on customer service and scheduling high-quality meetings between the attending executives and investors. Investor Summit sets the bar for quality service in a space traditionally dominated by banks who focus more on selling their services than on building the connections your company needs to succeed. Conference organizers have facilitated countless valuable interactions for the event's presenting companies, which have often led to increased exposure, market value appreciation, and long-term growth.
For more information visit investorsummitgroup.com
- ACCO Brands Corporation
- Alimera Sciences Inc.
- Annovis Bio
- AquaBounty Technologies Inc.
- Arch Therapeutics Inc.
- Artelo Biosciences Inc.
- Avalon Advanced Materials
- Bellicum Pharmaceuticals
- C-Bond Systems Inc.
- Endra Life Sciences
- Energy Focus Inc.
- Equillium Inc.
- Exro Technologies Inc.
- GreenPower Motor Company Inc.
- Hecla Mining Company
- Heidrick & Struggles International
- Helius Medical Technologies
- Heritage Global Inc.
- Ideal Power
- IMAC Holdings Inc.
- Lincoln Educational Services Corp.
- MamaMancini's Holdings Inc.
- Marrone Bio
- Medicenna Therapeutics
- Milestone Scientific
- My Size Inc.
- Nephros Inc.
- New Age Beverages Corporation
- Nova Leap Health Corp.
- Oblong Inc.
- OncoSec Medical Inc.
ACCO Brands Corporation (NYSE: ACCO)
ACCO Brands Corporation (NYSE: ACCO) is one of the world's largest designers, marketers and manufacturers of branded academic, consumer and business products. ACCO Brands' widely recognized brands include AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones®, and many others. The company's products are sold in more than 100 countries around the world. For more information, visit the company's website at www.accobrands.com
Alimera Sciences Inc. (NASDAQ: ALIM)
Alimera Sciences Inc. (NASDAQ: ALIM) is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people globally. The company's vision is for Alimera to become synonymous with good retinal health. For more information, visit the company's website at www.alimerasciences.com
Annovis Bio (NYSE American: ANVS)
Annovis Bio (NYSE American: ANVS) is a clinical-stage drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down syndrome (AD-DS). Annovis believes it is the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. The company expects its treatment to improve memory loss and dementia associated with AD and AD-DS as well as body and brain function in PD. Annovis has an ongoing phase 2a study in AD patients and plans to commence a second phase 2a study in PD patients. For more information, visit the company's website at www.annovisbio.com
AquaBounty Technologies Inc. (NASDAQ: AQB)
AquaBounty Technologies Inc. (NASDAQ: AQB) is a commercial aquaculture company focused on improving efficiency, sustainability, and profitability, leveraging decades of biotechnology expertise to ensure the availability of high-quality seafood to meet global consumer demand. By 2016, both the U.S. Food and Drug Administration and Health Canada approved the company's AquAdvantage salmon as the first and only bioengineered animal protein for human consumption. The company's AquAdvantage fish program is based upon a single, specific molecular modification that results in more rapid growth in early development, resulting in a 70 percent increase in annual production output for AquAdvantage versus conventional Atlantic salmon. For more information, visit the company's website at www.seafoodsource.com
Arch Therapeutics Inc. (OTCQB: ARTH)
Arch Therapeutics Inc. (OTCQB: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. The company is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include AC5 Topical Gel, AC5 Topical Hemostat and AC5 Surgical Hemostat. For more information, visit the company's website at www.archtherapeutics.com
Artelo Biosciences Inc. (NASDAQ: ARTL)
Artelo Biosciences (NASDAQ: ARTL) is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading-edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com
Avalon Advanced Materials (OTCQB: AVLNF)
Avalon Advanced Materials Inc. (OTCQB: AVLNF) is a Canadian mineral development company specializing in sustainably produced materials for clean technology. The company now has four advanced stage projects, providing investors with exposure to lithium, tin and indium, as well as rare earth elements, tantalum, cesium and zirconium. Avalon is currently focusing on developing its Separation Rapids Lithium Project near Kenora, Ontario, while looking at several new project opportunities, including reactivating its 100%-owned Lilypad Tantalum-Cesium Project in northwestern Ontario. Social responsibility and environmental stewardship are corporate cornerstones. For more information, visit the company's website at www.avalonadvancedmaterials.com
Bellicum Pharmaceuticals (NASDAQ: BLCM)
Bellicum (NASDAQ: BLCM) is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T and CAR-NK cell therapies. Bellicum's lead GoCAR-T® candidate, BPX-601, is designed to be a more efficacious CAR-T cell product capable of overriding key immune inhibitory mechanisms. For more information, visit the company's website at www.bellicum.com
C-Bond Systems Inc. (OTC: CBNT)
C-Bond Systems (OTC: CBNT) (OTC: CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The company's Transportation Solutions Group sells C-Bond NanoShield®, a liquid solution applied directly to automotive windshields, sold through distributors. The company's Safety Solutions Group sells ballistic-resistant glass solutions and FN NANO Coating directly to private enterprises, schools, hospitals and government agencies. For more information, visit the company's website at www.cbondsystems.com
Endra Life Sciences (NASDAQ: NDRA)
ENDRA Life Sciences Inc. (NASDAQ: NDRA) is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology that mirrors some applications similar to CT or MRI, but at 50X lower cost, at the point of patient care. TAEUS is designed to work in concert with one million ultrasound systems in global use today. TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor NAFLD and NASH, chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. For more information, visit the company's website at www.endrainc.com
Energy Focus Inc. (NASDAQ: EFOI)
Energy Focus (NASDAQ: EFOI) is an industry-leading innovator of sustainable LED lighting technologies and solutions. As the creator of the first flicker-free original LED products on the U.S. market, Energy Focus products provide extensive energy and maintenance savings, and aesthetics, safety, health and sustainability benefits over conventional lighting. Since 2007, Energy Focus has installed approximately 900,000 lighting products across U.S. Navy fleet, including TLEDs, waterline security lights, explosion-proof globes and berth lights, saving more than five million gallons of fuel and 300,000 man-hours in lighting maintenance annually. Energy Focus is headquartered in Solon, Ohio. For more information, visit the company's website at www.energyfocus.com
Equillium Inc. (NASDAQ: EQ)
Equillium Inc. (NASDAQ: EQ) is a clinical-stage biotechnology company that develops products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium's initial product candidate, itolizumab (EQ001), is a clinical-stage, first-in-class monoclonal antibody that selectively targets the CD6-ALCAM pathway. This pathway plays a central role in modulating the activity and trafficking of T cells that drive a number of immuno-inflammatory diseases. Equillium acquired rights to itolizumab through an exclusive partnership with Biocon Limited. Itolizumab has the potential to be a best-in-class disease modifying therapeutic and is advancing itolizumab into clinical development in the following severe immuno-inflammatory disorders: uncontrolled asthma, acute graft-versus-host disease, and lupus nephritis. For more information, visit the company's website at www.equilliumbio.com
Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro's patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability. For more information, visit the company's website at www.exro.com
GreenPower Motor Company Inc. (TSX.V: GPV)
GreenPower Motor Company Inc. (TSX.V: GPV) designs, builds and distributes a full suite of high-floor and low-floor vehicles, including transit buses, school buses, shuttles, a cargo van and a double decker. GreenPower employs a clean-sheet design to manufacture all-electric buses that are purpose built to be battery powered with zero emissions. GreenPower integrates global suppliers for key components, such as Siemens or TM4 for the drive motors, Knorr for the brakes, ZF for the axles and Parker for the dash and control systems. This OEM platform allows GreenPower to meet the specifications of various operators while providing standard parts for ease of maintenance and accessibility for warranty requirements. For more information, visit the company's website at www.greenpowerbus.com
Hecla Mining Company (NYSE: HL)
Hecla Mining Company (NYSE: HL) is a leading low-cost U.S. silver producer with operating mines in Alaska, Idaho and Mexico, and is a growing gold producer with operating mines in Quebec, Canada and Nevada. Hecla promotes a culture of innovation by driving and embracing technologies that have a significant impact in improving the health and safety of our employees, improving environmental performance, and increasing mine-operating efficiency and productivity. The Company also has exploration and pre-development properties in eight world-class silver and gold mining districts in the U.S., Canada, and Mexico. For more information, visit the company's website at www.hecla-mining.com
Heidrick & Struggles International (NASDAQ: HSII)
Heidrick & Struggles (NASDAQ: HSII) assists the world's top organizations with their senior-level talent and leadership needs. Specializing in executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services, the company pioneered the profession of executive search nearly seven decades ago. Today, Heidrick & Struggles Operates from principal business centers in North America, Latin America, Europe, the Middle East, Africa and Asia Pacific. For more information, visit the company's website at www.heidrick.com
Helius Medical Technologies (TSX: HSM) (NASDAQ: HSDT) is a neurotech company focused on neurological wellness. The company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The company's first product in development is the Portable Neuromodulation Stimulator (PoNS™). The stimulator delivers neurostimulation via the tongue, which has been shown in clinical studies to improve the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. For more information, visit the company's website at www.heliusmedical.com
Heritage Global Inc. (CSE: HGP) (OTCQB: HGBL) is a diversified financial services company providing asset-based acquisition, disposition, valuation, and lending services. Heritage Global focuses on identifying, valuing, acquiring and monetizing underlying tangible and intangible assets across 28 global sectors. The company acts as an adviser, as well as a principal, acquiring or brokering turnkey manufacturing facilities, surplus industrial machinery and equipment, industrial inventories, accounts receivable portfolios, real estate, intellectual property, and entire business enterprises. For more information, visit the company's website at www.heritageglobalinc.com
Ideal Power (NASDAQ: IPWR)
Ideal Power (NASDAQ: IPWR) is pioneering the development of its broadly patented bi-directional power switches, creating highly efficient and ecofriendly energy control solutions for industrial, alternative energy, military and automotive applications. The company is focused on its patented Bi-directional, Bi-polar Junction Transistor (B-TRAN™) semiconductor technology. B-TRAN™ is a unique double-sided bi-directional AC switch able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN™ modules will reduce conduction and switching losses, complexity of thermal management and operating cost in medium voltage AC power switching and control circuitry. For more information, visit the company's website at www.IdealPower.com
IMAC Holdings Inc. (NASDAQ: IMAC)
IMAC Holdings Inc. (NASDAQ: IMAC) owns or manages IMAC Regeneration Centers, which combine life science advancements with traditional medical care for movement-restricting diseases and conditions. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. IMAC's outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. The centers are currently located in Illinois, Kentucky, Missouri, and Tennessee, with an FDA Registered laboratory and research and development site in Miami, Florida. For more information, visit the company's website at www.imacregeneration.com
Lincoln Educational Services Corp. (NASDAQ: LINC)
Lincoln Educational Services (NASDAQ: LINC) is a leading provider of hands-on, post-secondary career education solving America's skills gap by serving three key sectors: transportation, skilled trades and healthcare. After restructuring its operations, Lincoln has achieved nine consecutive quarters of growth and is now a profitable business with strong growth opportunities that will accelerate its profitability. For more information, visit the company's website at www.lincolntech.edu
Marrone Bio (NASDAQ: MBII)
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI's pro-farm, Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. For more information, visit the company's website at www.marronebio.com
MamaMancini's Holdings Inc. (OTCQB: MMMB)
MamaMancini's Holdings, Inc. (OTCQB: MMMB) is a marketer and distributor of specialty prepared, refrigerated and frozen all-natural Italian foods. MamaMancini's product portfolio consists of over 20 products including meatballs, meat loaf, chicken parmesan, sausages and pasta bowl kits, with beef, turkey, chicken and pork varieties. The company's products are sold in over 45,000 locations nationwide, including at well-known retailers such as Sam's Club, Whole Foods, Publix, Costco and Albertsons, as well as through national distributors such as Sysco and United Natural Foods. The company has a major presence on QVC, the largest direct to consumer marketer in the world. For more information, visit the company's website at www.mamamancinis.com
Medexus (TSX.V: MDP)
Medexus (TSX.V: MDP) is a leading specialty pharmaceutical company with a strong North American commercial platform. The company's vision is to provide the best healthcare products to healthcare professionals and patients, through its core values of quality, innovation, customer service and teamwork. Medexus is focused on the therapeutic areas of auto-immune disease, hematology and allergy. The company's leading products are: IXINITY®, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B – a hereditary bleeding disorder characterized by a deficiency of clotting factor IX in the blood, which is necessary to control bleeding; Rasuvo™ and Metoject®, a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; and Rupall®, an innovative allergy medication with a unique mode of action. For more information, visit the company's website at www.medexus.com
Medicenna Therapeutics (TSX: MDNA) (OTCQB: MDNAF) is a clinical-stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a broad range of cancers. Medicenna's long-acting IL2 Superkine assets, MDNA19 and MDNA11, are best-in-class next-generation IL-2WEs in development with superior CD122 binding without CD25 affinity and therefore preferentially stimulating cancer killing effector T cells and NK cells when compared to competing IL-2 programs. It is anticipated that MDNA19 or MDNA11 will be ready for the clinic in 2021. For more information, visit the company's website at www.medicenna.com
Milestone Scientific (NYSE American: MLSS)
Milestone Scientific Inc. (NYSE American: MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is its technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information, visit the company's website at www.milestonescientific.com
My Size Inc. (TASE: MYSZ) (NASDAQ: MYSZ)
My Size Inc. (TASE: MYSZ) (NASDAQ: MYSZ) has developed a unique measurement technology based on sophisticated algorithms and cutting-edge technology with broad applications including the apparel, e-commerce, DIY, shipping and parcel delivery industries. This proprietary measurement technology is driven by several algorithms which are able to calculate and record measurements in a variety of novel ways. For more information, visit the company's website at www.mysizeid.com
Nephros Inc. (NASDAQ: NEPH)
Nephros (NASDAQ: NEPH) is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the healthcare, food service, hospitality and convenience store markets. For more information, visit the company's website at www.nephros.com
New Age Beverages Corporation (NASDAQ: NBEV)
New Age Beverages Corporation (NASDAQ: NBEV) is a Colorado based healthy products company dedicated to inspiring and educating consumers to "Live Healthy." The company is the only omni-channel distribution company with access to traditional retail, e-commerce, direct-to-consumer, and medical channels across 60 countries worldwide. New Age markets a portfolio of better-for-you products including the brands Tahitian Noni, TeMana, Nestea, Volvic, Illy Coffee, Evian, Búcha Live Kombucha, 'Nhanced and others. For more information, visit the company's website at www.newage.com
Nova Leap Health (TSXV: NLH) (OTC: NVLPF) is an acquisitive home health care services company operating in one of the fastest growing industries in the U.S. and Canada. The company performs a vital role within the continuum of care with an individual and family-centered focus, particularly those requiring dementia care. Nova Leap achieved the No. 10 ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The company is geographically diversified with operations in five different U.S. states – Vermont, New Hampshire, Massachusetts, Rhode Island and Oklahoma – as well as Nova Scotia, Canada. For more information, visit the company's website at www.novaleaphealth.com
Oblong Inc. (NYSE American: OBLG)
Oblong Industries' (NYSE American: OBLG) innovative IP-protected technologies change the way people work, create, and communicate. With roots in more than two decades of research at the MIT Media Lab, Oblong's flagship product Mezzanine™ is the technology platform that defines the next era of computing: simultaneous multi-user, multi-screen, multi-device, multi-location for dynamic and immersive visual collaboration. Oblong is headquartered in Los Angeles and supplies Mezzanine systems to Fortune 500 enterprise customers and reseller partners. For more information, visit the company's website at www.oblong.com
OncoSec Medical Inc. (NASDAQ: ONCS)
OncoSec Medical (NASDAQ: ONCS) is a late-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead immunotherapy investigational product candidate, TAVO, enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions. OncoSec has built a deep and diverse clinical pipeline utilizing TAVO as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors. Results from recently completed clinical studies of TAVO have demonstrated a local immune response, and subsequently, a systemic effect as either a monotherapy or combination treatment approach. For more information, visit the company's website at www.oncosec.com
Oragenics Inc. (NYSE: OGEN)
Oragenics (NYSE: OGEN) is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. The company has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much-needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat and esophagus. For more information, visit the company's website at www.oragenics.com
PDS Biotechnology Corporation (NASDAQ: PDSB)
PDS Biotech (NASDAQ: PDSB) is a clinical-stage immunotherapy company with a growing pipeline of cancer immunotherapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell activating technology platform. Versamune® effectively delivers disease-specific proteins for in vivo uptake and processing by the immune system, while also activating the critical type 1 interferon immunological pathway. This results in the production of potent disease-specific killer T-cells as well as neutralizing antibodies. PDS Biotech has engineered multiple therapies, based on combinations of Versamune® and disease-specific antigens, designed to train the immune system to better recognize disease cells and effectively attack and destroy them. For more information, visit the company's website at www.pdsbiotech.com
Safeguard Scientific (NYSE: SFE)
Historically, Safeguard Scientifics (NYSE: SFE) has provided capital and relevant expertise to fuel the growth of technology-driven businesses. The company targets firms that are capitalizing on the next wave of enabling technologies, with a particular focus on the Internet of Everything, enhanced security and predictive analytics. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. For more information, visit the company's website at www.safeguard.com
SELLAS Life Sciences Group (NASDAQ: SLS)
SELLAS Life Sciences Group Inc. (NASDAQ: SLS) is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S (GPS), is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets a broad spectrum of hematologic cancers and solid tumor indications. In January 2020, GPS entered a pivotal Phase 3 clinical trial in patients with AML. For more information, visit the company's website at www.sellaslifesciences.com
ShiftPixy (NASDAQ: PIXY)
ShiftPixy (NASDAQ: PIXY) is a disruptive human capital management platform, revolutionizing employment in the Gig Economy by delivering a next-gen mobile engagement technology to help businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens and better connect with a ready-for-hire workforce. With expertise rooted in management's nearly 25 years of workers' compensation and compliance programs experience, ShiftPixy adds a needed layer for addressing compliance and continued demands for equitable employment practices in the growing Gig Economy. For more information, visit the company's website at www.shiftpixy.com
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D® brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D® for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs' software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, visit the company's website at www.sigmalabsinc.com
Sono-Tek Corporation (OTCQX: SOTK)
Sono-Tek Corporation (OTCQX: SOTK) is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive. Sono-Tek's growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for its customers' products and processes. For more information, visit the company's website at www.sono-tek.com
Tinybeans Group Limited (OTC: TNYYF)
Tinybeans Group Limited (OTC: TNYYF) is a Sydney and New York-based, social media platform focused on enabling families and friends to connect and share moments with each other. The company began around the virtues that everyone in the family, no matter who they are, should celebrate the everyday moments of the children in the family. Each family member can then love and comment on these moments. The company started in Sydney in 2012 as a solution for sharing of family moments on a secure and private social media platform and now services users in across over 160 countries. For more information, visit the company's website at www.tinybeans.com
Timber Pharmaceuticals was founded in 2019 to develop treatments for unmet needs in medical dermatology. The company's particular focus is on rare diseases or conditions of the skin for which there are no current treatments. Rare skin diseases are among the most neglected therapeutic areas in the pharmaceutical industry. Over 450 different rare skin diseases have been identified, and yet there have been only 17 FDA approvals for eight different rare dermatological conditions since the Orphan Drug Act was passed in 1983. Timber was formed around the collaboration of three companies with demonstrated experience in all phases of drug development and clinical research. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. For more information, visit the company's website at www.timberpharma.com
Tonix Pharmeceuticals Holding Corp. (NASDAQ: TNXP)
Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics. The company's focus is on developing small molecules and biologics to treat psychiatric, pain and addiction conditions. Tonix's mission is to improve the lives of patients by identifying, researching and developing promising therapies that have the potential to address needs not currently fulfilled by existing products. For more information, visit the company's website at www.tonixpharma.com
TransGlobe Energy (NASDAQ: TGA)
TransGlobe Energy Corporation (NASDAQ: TGA) is a cash flow focused oil and gas exploration and development company whose current activities are concentrated in the Arab Republic of Egypt and Canada. TransGlobe's common shares trade on the Toronto Stock Exchange and the AIM market of the London Stock Exchange under the symbol 'TGL' and on the Nasdaq Exchange under the symbol 'TGA'. For more information, visit the company's website at www.trans-globe.com
Trxade Group Inc. (NASDAQ: MEDS)
Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry. For more information, visit the company's website at www.trxade.com
Ur-Energy Inc. (NYSE: URG)
Ur‐Energy (NYSE: URG) is a uranium mining company operating the Lost Creek in‐situ recovery uranium facility in south‐central Wyoming. The company has produced, packaged and shipped approximately 2.6 million pounds from Lost Creek since the commencement of operations. Applications are under review by various agencies to incorporate Ur-Energy's LC East project area into the Lost Creek permits, and to construct and operate at its Shirley Basin Project. Ur‐Energy is engaged in uranium mining, recovery and processing activities, including the acquisition, exploration, development and operation of uranium mineral properties in the United States. Ur‐Energy's corporate office is in Littleton, Colorado; its registered office is in Ottawa, Ontario. For more information, visit the company's website at www.ur‐energy.com
VIQ Solutions (TSX.V: VQS) (OTCQX: VQSLF) is a global expert in video capture software and audio recording with voice-to-text capabilities. VIQ provides a cyber-secure AI technology and service platform to law enforcement, immigration, medical, legal, insurance, courts, and transcription service providers, enabling them to unlock the value of their enterprise digital media and streamline their document-creation workflow, using artificial intelligence tools for measurable business gains. For more information, visit the company's website at www.viqsolutions.com
Western Magnesium (OTCQB: MLYF)
Western Magnesium's (OTCQB: MLYF) goal is to be a low-cost producer of green, primary magnesium metal, a strategic commodity prized for its strength and light weight. Unlike outdated and costly production processes, Western Magnesium looks to use a continuous silicothermic process to produce magnesium, which significantly reduces labor and energy costs relative to current methods and processes, while being environmentally friendly. For more information, visit the company's website at www.westmagcorp.com